A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27

Cell Death and Disease

Volumn 6, Issue 8, 2015, Pages

  Qiu, M ^a,b   Xu, Y ^a,b   Wang, J ^a   Zhang, E ^b   Sun, M ^b   Zheng, Y ^a   Li, M ^a   Xia, W ^a,b   Feng, D ^a,b   Yin, R ^a   Xu, L ^a  

^a JIANGSU CANCER HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LONG UNTRANSLATED RNA; LUNG ADENOCARCINOMA TRANSCRIPT 1 PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN P27; SMAD4 PROTEIN; SMALL NUCLEAR RNA U1; SUZ12 PROTEIN; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HISTONE; SUZ12 PROTEIN, HUMAN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL CYCLE REGULATION; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; EPIGENETIC REPRESSION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; UPREGULATION; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ADENOCARCINOMA; AGED; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; OLIGORIBONUCLEOTIDES, ANTISENSE; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84989282618     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.203     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Lung cancer in never smokers-A review. Eur J Cancer 2012; 48: 1299-1311.
3. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005; 40: 90-97.
4. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012; 150: 1121-1134.
5. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
6. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: Insights into functions. Nat Rev Genet 2009; 10: 155-159.
7. Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 2014; 344: 310-313.
8. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013; 493: 231-235.
9. Hung CL, Wang LY, Yu YL, Chen HW, Srivastava S, Petrovics G et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA 2014; 111: 18697-18702.
10. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
11. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013; 49: 1083-1096.
12. Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 2014; 159: 1110-1125.
13. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage nonsmall cell lung cancer. Oncogene 2003; 22: 8031-8041.
14. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011; 18: 1243-1250.
15. Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 2011; 6: 1984-1992.
16. Wang L, Zhao Y, Bao X, Zhu X, Kwok YK, Sun K et al. LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Res 2015; 25: 335-350.
17. Ranzani V, Rossetti G, Panzeri I, Arrigoni A, Bonnal RJ, Curti S et al. The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. Nat Immunol 2015; 16: 318-325.
18. Kornfeld JW, Bruning JC. Regulation of metabolism by long, non-coding RNAs. Front Genet 2014; 5: 57.
19. Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH et al. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst 2015; e-pub ahead of print 6 February 2015; doi: 10.1093/jnci/dju505.
20. Uchida S, Dimmeler S. Long noncoding RNAs in cardiovascular diseases. Circ Res 2015; 116: 737-750.
21. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res 2011; 71: 3-7.
22. Qiu MT, Xu YT, Yang X, Wang J, Hu JW, Xu L et al. CCAT2 is a lung adenocarcinomaspecific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol 2014; 35: 5375-5380.
23. Prieto C, Risueno A, Fontanillo C, De las Rivas J. Human gene coexpression landscape: Confident network derived from tissue transcriptomic profiles. PLoS One 2008; 3: E3911.
24. Vermeirssen V, Barrasa MI, Hidalgo CA, Babon JA, Sequerra R, Doucette-Stamm L et al. Transcription factor modularity in a gene-centered C. elegans core neuronal protein-DNA interaction network. Genome Res 2007; 17: 1061-1071.
25. Basak S, Ramesh AM, Kesari V, Parida A, Mitra S, Rangan L. Genetic diversity and relationship of Hedychium from Northeast India as dissected using PCA analysis and hierarchical clustering. Meta Gene 2014; 2: 459-468.
26. Cameron DA, Middleton FA, Chenn A, Olson EC. Hierarchical clustering of gene expression patterns in the Eomes+lineage of excitatory neurons during early neocortical development. BMC Neurosci 2012; 13: 90.
27. Nayak RR, Kearns M, Spielman RS, Cheung VG. Coexpression network based on natural variation in human gene expression reveals gene interactions and functions. Genome Res 2009; 19: 1953-1962.
28. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54: 1679-1689.
29. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci USA 2006; 103: 982-987.
30. Tessema M, Willink R, Do K, Yu YY, Yu W, Machida EO et al. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 2008; 68: 1707-1714.
31. Lin MF, Jungreis I, Kellis M. PhyloCSF: A comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics 2011; 27: I275-i282.
32. Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W, CPAT. Coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Res 2013; 41: E74.
33. Pathmanathan N, Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol 2013; 66: 512-516.
34. Yoon MK, Mitrea DM, Ou L, Kriwacki RW. Cell cycle regulation by the intrinsically disordered proteins p21 and p27. Biochem Soc Trans 2012; 40: 981-988.
35. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009; 106: 11667-11672.
36. Muppirala UK, Honavar VG, Dobbs D. Predicting RNA-protein interactions using only sequence information. BMC Bioinformatics 2011; 12: 489.
37. Agostini F, Zanzoni A, Klus P, Marchese D, Cirillo D, Tartaglia GG. catRAPID omics: A web server for large-scale prediction of protein-RNA interactions. Bioinformatics 2013; 29: 2928-2930.
38. Brockdorff N. Noncoding RNA and polycomb recruitment. RNA 2013; 19: 429-442.
39. Baty F, Rothschild S, Fruh M, Betticher D, Droge C, Cathomas R et al. EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. PLoS One 2013; 8: E72966.
40. Yu W, Qiao Y, Tang X, Ma L, Wang Y, Zhang X et al. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal 2014; 26: 2961-2968.
41. Arab K, Park YJ, Lindroth AM, Schafer A, Oakes C, Weichenhan D et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell 2014; 55: 604-614.
42. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R et al. CCAT2, a novel long non-coding RNA in breast cancer: Expression study and clinical correlations. Oncotarget 2013; 4: 1748-1762.
43. Yang YW, Flynn RA, Chen Y, Qu K, Wan B, Wang KC et al. Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency. Elife 2014; 3: E02046.
44. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142: 409-419.
45. Chang CJ, Hung MC. The role of EZH2 in tumour progression. Br J Cancer 2012; 106: 243-247.
46. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res 2005; 11: 3974-3986.
47. Shen J, Yin JY, Li XP, Liu ZQ, Wang Y, Chen J et al. The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PLoS One 2014; 9: E96008.
48. Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007; 39: 1338-1349.
49. Yang X, Zhang Z, Qiu MT, Hu JW, Fan XH, Wang J et al. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer. Cancer Lett 2013; 341: 265-273.